ClinicalTrials.gg
Drug

Trospium chloride clinical trials

A product of Trospium; its studies count on that page too.

studies test it
18
open now
9
in phase 3
4
first study started
2009

How each study uses trospium chloride is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the trospium chloride studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
28 May 2004 · SANCTURA · NDA 021595 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Trospium Chloride
7
Sanctura XR®
3
Sanctura XR™ 60 mg
3

Brand

Sanctura
1

Development codes

BMS-986520
1

In one entry with another drug

Given together, or one or the other

KarXT
7
Xanomeline/trospium chloride
4
Xanomeline/Trospium Chloride Capsule
2

Studies by the year they started

18 studies that test it; most in 2025 (6)

Studies that test trospium chloride, by start year
YearStudies
20093
20102
20131
20161
20201
20256
20264

By phase

A phase 1/2 study counts in both.

Phase 1
5
Phase 2
1
Phase 3
4
Phase 4
8
No phase
1

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 14 · Other 4

Allergan (5) · Bristol-Myers Squibb (5) · Karuna Therapeutics, Inc., a Bristol Myers Squibb company (3) · Karuna Therapeutics (1) · University of North Carolina, Chapel Hill (1) · Collaborative Neuroscience Research, LLC (1) · New York State Psychiatric Institute (1) · Mansoura University (1)

Often tested with

Tested in the same studies.

Xanomeline (10) · Metformin (1) · Tamsulosin (1)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 4, 1 in phase 3

Studies that test trospium chloride, phase 3 first.

Studies

Open first, then newest update. How each study uses trospium chloride is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 18

Given beside what is tested · 10 — trospium chloride is usual care or a partner of the new treatment
As the comparator · 2 — what is tested is compared with trospium chloride

Codes

What other systems call trospium chloride · ClinicalTrials.gg INT002272

  • MeSH (NLM) C003330trospium chlorideConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 1E6682427ETROSPIUM CHLORIDEConfirmed FDA, NLM, Wikidata
  • RxNorm 38891Confirmed FDA, Wikidata
  • Wikidata Q27252312trospium chlorideConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C61995Trospium ChlorideOne source FDA
  • DrugBank DBSALT000883One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.